Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2027

Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2027

  • October 2018 •
  • 83 pages •
  • Report ID: 5299564
DelveInsight’s ‘Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2027’ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Idiopathic Pulmonary Fibrosis in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.

Geography Covered
• The United States
• EU5 (Germany, France, Italy, Spain and the United Kingdom)
• Japan

Study Period: 2016-2027

Idiopathic Pulmonary Fibrosis Epidemiology
The Idiopathic Pulmonary Fibrosis (IPF) epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. The epidemiology data for Idiopathic Pulmonary Fibrosis are studied through all possible division to give a better understanding about the Disease scenario in 7MM. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Idiopathic Pulmonary Fibrosis Epidemiology Segmentation
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology (total prevalent cases, diagnosed prevalent cases, gender-specific cases, age-specific cases and severity specific prevalence) scenario of Idiopathic Pulmonary Fibrosis (IPF) in the 7MM covering United States, EU5 countries (Germany, Spain, Italy, France and United Kingdom) and Japan from 2016-2027.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the total number of diagnosed prevalent population of Idiopathic Pulmonary Fibrosis was found to be 261,482, in the year 2016.

Report Scope
• The report covers detailed overview of Idiopathic Pulmonary Fibrosis explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• The report provides the insight about the historical and forecasted patient pool of Idiopathic Pulmonary Fibrosis in 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The Report assesses the disease risk and burden and highlights the unmet needs of the disease
• The Report helps to recognize the growth opportunities in the 7MM with respect to the patient population
• The report provides the segmentation of the disease epidemiology by sub-type i.e., Age-specific & Gender-specific Idiopathic Pulmonary Fibrosis and severity specific in 7MM

Key strengths
• 10 Year Forecast of Idiopathic Pulmonary Fibrosis epidemiology
• 7MM Coverage
• Total Prevalent Cases of IPF
• Prevalent Cases according to segmentation: Age-specific, Gender- specific prevalence and Severity-specific
• Diagnosed cases of IPF

Key assessments
• Patient Segmentation
• Disease Risk & Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population